Ensysce Biosciences Inc.

NASDAQ: ENSC · Real-Time Price · USD
2.21
0.02 (0.91%)
At close: May 30, 2025, 3:59 PM
2.22
0.68%
After-hours: May 30, 2025, 05:44 PM EDT

Ensysce Biosciences Revenue Breakdown

Period Ending Dec 31, 2023 Dec 31, 2022
M P A R Revenue n/a 2.01M
M P A R Revenue Growth -100.00% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017
Selling, General, and Administrative Revenue 1.4M 1.08M 1.08M 1.19M 1.37M 1.44M 1.23M 1.14M 1.55M 1.19M 1.69M 1.95M 2.27M 1.45M 16.37M 393.91K 490.47K 256.45K 339.42K 281.35K 277.69K n/a n/a n/a n/a n/a n/a n/a n/a 141.69K n/a
Selling, General, and Administrative Revenue Growth +30.09% -0.55% -8.96% -13.12% -4.74% +17.12% +7.63% -26.64% +30.41% -29.31% -13.57% -13.88% +55.81% -91.12% +4056.48% -19.69% +91.26% -24.45% +20.64% +1.32% n/a n/a n/a n/a n/a n/a n/a n/a -100.00% n/a n/a
Research and Development Revenue 1.89M 3.8M 1.69M 947.23K 778.9K 2.23M 1.91M 1.64M 1.8M 6.44M 4.76M 5.31M 3.14M 2.19M 1.71M 463.22K 284.38K 1.25M 892.99K 1.4M 838.97K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth -50.42% +124.92% +78.49% +21.61% -65.11% +16.60% +16.50% -8.48% -72.12% +35.45% -10.45% +69.14% +43.52% +27.60% +270.16% +62.89% -77.31% +40.36% -36.41% +67.38% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a